mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP- 2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines

Thyroid

Volumn 8, Issue 3, 1998, Pages 203-214

  Hofmann, A ^a   Laue, S ^c   Rost, A K ^a   Scherbaum, W A ^b   Aust, G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; GELATINASE B; MESSENGER RNA; STROMELYSIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RNA TRANSCRIPTION; THYROID CARCINOMA;

EID: 0031895311     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.203     Document Type: Article

References (38)

1. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G 1996 The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase a and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271:17119-17123.
2. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA, Goldberg GI 1988 H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587.
3. Wilheilm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI 1989 SV40-transformed human lung fibroblasts secrete a 92-kda type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221.
4. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G 1996 Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131.
5. Fridman R, Toth M, Pena D, Mobashery S 1995 Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55:2548-2555.
6. Campo E, Merino MJ, Liotta L, Neumann R, Stetler-Stevenson W 1992 Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue. Hum Pathol 23:1395-1401.
7. Zedenius J, Stahle-Backdahl M, Enberg U, Grimelius L, Larsson C, Wallin G, Backdahl M 1996 Stromal fibroblasts adjacent to invasive thyroid tumors: Expression of gelatinase A but not stromelysin 3 mRNA. World J Surg 20:101-106.
8. Ries C, Petrides PE 1995 Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 376:345-355.
9. Stetler-Stevenson WG, Krutzsch HC, Liotta LA 1989 Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17347-17378.
10. Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR 1994 Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269:9352-9360.
11. Kishnani NS, Staskus PW, Yang TT, Masiarz FR, Hawkes SP 1995 Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix. Matrix Biol 14:479-488.
12. Apte SS, Olsen BR, Murphy G 1995 The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270:14313-14318.
13. Aust G, Hofmann A, Laue S, Rost A, Köhler T, Scherbaum WA 1997 Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of MMP-1 and TIMP-1 mRNA and protein. Thyroid 7:713-724.
14. Davies TF 1985 Co-cultures of human thyroid monolayer cultures of human thyroid monolayer cells and autologous T cells-impact of HLA class II antigen expression. J Clin Endocrinol Metab 61:418-423.
15. Saalbach A, Anderegg U, Schnabel E, Herrmann K, Haustein UF 1996 Novel fibroblast-specific monoclonal antibodies: Properties and specificities. J Invest Dermatol 106: 1308-1313.
16. Saalbach A, Aust G, Anderegg U, Haustein UF, Herrmann K 1997 The fibroblasts-specific MAb AS02: A novel tool for detection and elimination of human fibroblasts. Cell Tissue Res 290:593-599.
17. Aust G, Heuer M, Laue S, Lehmann I, Hofmann A, Heldin N-E, Scherbaum WA 1996 Expression of TNA-alpha mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clin Exp Immunol 105:148-154.
18. Mark J, Ekedahl C, Dahlenfors R, Westermark B 1987 Cytogenetical observations in five human anaplastic thyroid carcinomas. Hereditas 107:163-174.
19. Heldin NE, Cvejic D, Smeds S, Westermark B 1991 Coexpression of functionally active receptors for thyrotropin and platelet-derived growth factor in human thyroid carcinoma cells. Endocrinology 129:2187-2193.
20. Ito T, Seyama T, Hayashi Y, Hayashi T, Dohi K, Mizuno T, Iwamoto KS, Tsuyama N, Nakamura N, Akiyama M 1994 Establishment of two human thyroid carcinoma cell lines (8305C, 8505C) bearing p53 gene mutations. Int J Oncol 4:583-586.
21. Platzer C, Ode-Hakim S, Reinke P, Docke WD, Ewert R, Volk HD 1994 Quantitative PCR analysis of cytokine transcription patterns in peripheral mononuclear cells after anti-CD3 rejection therapy using two novel multispecific competitor fragments. Transplantation 58:264-268.
22. Celi FS, Zenilman ME, Schuldiner AR 1993 A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res 21:1047
23. Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG 1990 Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184-6191.
24. Nomura H, Sato H, Seiki M, Mai M, Okada Y 1995 Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55:3263-3266.
25. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P 1995 Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734.
26. McDonnell S, Fingleton B 1993 Role of matrix metalloproteinases in invasion and metastasis: biology, diagnosis and inhibitors. Cytotechnology 12:367-384.
27. Tryggvason K, Hoyhtya M, Pyke C 1993 Type IV collagenases in invasive tumors. Breast Cancer Res Treat 24: 209-218.
28. Grigioni WF, D'Errico A, Fiorentino M, Baccarini P, Onisto M, Caenazzo C, Stetler-Stevenson WG, Garbisa S, Mancini AM 1994 Gelatinase A (MMP-2) and its mRNA detected in both neoplastic and stromal cells of tumors with different invasive and metastatic properties. Diagn Mol Pathol 3:163-169.
29. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y 1995 Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 71:1039-1045.
30. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA 1996 Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683-693.
31. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP 1992 Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12:168-184.
32. Unemori EN, Hibbs MS, Amento EP 1991 Constitutive expression of a 92-kd gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88:1656-1662.
33. Corcoran ML, Stetler-Stevenson WG 1995 Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J Biol Chem 270: 13453-13459.
34. Nuovo GJ, MacConnell PB, Simsir A, Valea F, French DL 1995 Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary dnas and their inhibitors with prognosis in cervical carcinoma. Cancer Res 55:267-275.
35. Gohji K, Fujimoto N, Fujii A, Komiyama T, Okawa J, Nakajima M 1996 Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection. Cancer Res 56:3196-3198.
36. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR 1993 Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res 5:19-28.
37. Grignon DJ, Sakr W, Toth M, Ravery V, Angulo J, Shamsa F, Pontes JE, Crissman JC, Fridman R 1996 High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 56:1654-1659.
38. Murashige M, Miyahara M, Shiraishi N, Saito T, Kohno K, Kobayashi M 1996 Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol 26:303-309.